Automation offers new opportunities to increase efficiency and reduce costs associated with post-marketing pharmacovigilance. Yet with patient safety at stake, the adoption of new technologies requires careful assessment...
Therapeutics
ICON's global team of experts has extensive experience in a broad of therapeutic areas
-
40%
Projects focused in oncology -
200
Clinical trials in vaccines over the past five years -
5,700 Sites
Worldwide in CNS studies
From initial strategy development all the way through to pricing and market access recommendations.
Arrange a Meeting
With one of our Therapeutic Experts today.
